CO4820441A1 - ANTIGEN BM 95 OF THE TICK BOOPHILUS MICROPLUS, ISOLATION, SEQUENCE, RECOMBINANT DNA, TRANSFORMED MICROORGANISMS AND VACCINE PREPARATION - Google Patents

ANTIGEN BM 95 OF THE TICK BOOPHILUS MICROPLUS, ISOLATION, SEQUENCE, RECOMBINANT DNA, TRANSFORMED MICROORGANISMS AND VACCINE PREPARATION

Info

Publication number
CO4820441A1
CO4820441A1 CO99010371A CO99010371A CO4820441A1 CO 4820441 A1 CO4820441 A1 CO 4820441A1 CO 99010371 A CO99010371 A CO 99010371A CO 99010371 A CO99010371 A CO 99010371A CO 4820441 A1 CO4820441 A1 CO 4820441A1
Authority
CO
Colombia
Prior art keywords
antigen
isolation
sequence
recombinant dna
vaccine preparation
Prior art date
Application number
CO99010371A
Other languages
Spanish (es)
Inventor
Garcia Jose Carlos Garcia
La Fuente Garcia Jose De Jesus De
Valle Manuel Rodriguez
Espinosa Carlos Antonio Montero
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of CO4820441A1 publication Critical patent/CO4820441A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un antígeno recombinante de garrapata Boophilus micropulus,caracterizado porque es el antígeno BM95 y comprenda la secuencia aminoacídica:MRGIALFVAAVSLIVEGTAESSICSDFGNEFCRNAECEVVPGAEDDFVCKCPRDNMYFNAAEKQCEYKDTCKTRECSYGRCVESNPSKGSCVCERSDDLTLQCKIKNDYATDCRNRGGTAKLRTDGFIGATCDCGEWGAMNKTTRNCVPTTCLRPDLTCKDLCEKNLLQRDSRCCQGWBTABCSAAOOADSYCSPGSPKGPDGQCKNACRTKEAGFVCKHGCRSTDKAYECTCPSGSTVAEDGITCKSISYTVSCTVEQKQTCRPTEDCRVQKGTVLCECPWNQHLVGDTCISDCVDKKCHEEFMDCGVYMMRQSCYCPWKSRKPGPNVNINERLLNEEYYYTVSFTPNISFDSDHCKRYEDRVLGAIRTSIGKEVFKVEILNCTQDIKARLLAEKPLSKYVLRKLQACEHPIGEWCMMYPKLLIKKNSATEIEEENLCDSLLKNQEAAYKGQNKCVKDNLFWFQCADGYTTTYEMTRGRLRRSVCKAGVSCNENEQLECANKGQICVYENGKANCQCPPDTKPGEIGCIEERTTCNPKEIQECQDKKLECVYKNHKAECKCPDDHECSRA recombinant antigen tick Boophilus micropulus, characterized in that the BM95 is antigen and comprising the amino acid sequence: MRGIALFVAAVSLIVEGTAESSICSDFGNEFCRNAECEVVPGAEDDFVCKCPRDNMYFNAAEKQCEYKDTCKTRECSYGRCVESNPSKGSCVCERSDDLTLQCKIKNDYATDCRNRGGTAKLRTDGFIGATCDCGEWGAMNKTTRNCVPTTCLRPDLTCKDLCEKNLLQRDSRCCQGWBTABCSAAOOADSYCSPGSPKGPDGQCKNACRTKEAGFVCKHGCRSTDKAYECTCPSGSTVAEDGITCKSISYTVSCTVEQKQTCRPTEDCRVQKGTVLCECPWNQHLVGDTCISDCVDKKCHEEFMDCGVYMMRQSCYCPWKSRKPGPNVNINERLLNEEYYYTVSFTPNISFDSDHCKRYEDRVLGAIRTSIGKEVFKVEILNCTQDIKARLLAEKPLSKYVLRKLQACEHPIGEWCMMYPKLLIKKNSATEIEEENLCDSLLKNQEAAYKGQNKCVKDNLFWFQCADGYTTTYEMTRGRLRRSVCKAGVSCNENEQLECANKGQICVYENGKANCQCPPDTKPGEIGCIEERTTCNPKEIQECQDKKLECVYKNHKAECKCPDDHECSR

CO99010371A 1998-02-20 1999-02-19 ANTIGEN BM 95 OF THE TICK BOOPHILUS MICROPLUS, ISOLATION, SEQUENCE, RECOMBINANT DNA, TRANSFORMED MICROORGANISMS AND VACCINE PREPARATION CO4820441A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1998024A CU22694A1 (en) 1998-02-20 1998-02-20 VACCINE PREPARATION BASED ON THE OBTAINING AND CHARACTERIZATION OF BOOPHILUS MICROPLUS ANTIGEN BM95

Publications (1)

Publication Number Publication Date
CO4820441A1 true CO4820441A1 (en) 1999-07-28

Family

ID=5459219

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99010371A CO4820441A1 (en) 1998-02-20 1999-02-19 ANTIGEN BM 95 OF THE TICK BOOPHILUS MICROPLUS, ISOLATION, SEQUENCE, RECOMBINANT DNA, TRANSFORMED MICROORGANISMS AND VACCINE PREPARATION

Country Status (6)

Country Link
AR (1) AR018103A1 (en)
BR (1) BR9900780A (en)
CO (1) CO4820441A1 (en)
CU (1) CU22694A1 (en)
UY (1) UY25393A1 (en)
ZA (1) ZA991320B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102013026625B1 (en) 2013-10-16 2022-04-26 Universidade Federal de Viçosa Recombinant peptide vaccine for tick control and nucleotide sequences encoding recombinant peptides

Also Published As

Publication number Publication date
BR9900780A (en) 2001-03-20
ZA991320B (en) 1999-08-19
UY25393A1 (en) 1999-09-27
AR018103A1 (en) 2001-10-31
CU22694A1 (en) 2001-07-31

Similar Documents

Publication Publication Date Title
ES2162917T3 (en) IMPROVEMENTS IN OR RELATING TO THE SUPPLY OF PEPTIDES.
EP2258383A3 (en) Antigenic peptides derived from telomerase
DE50112802D1 (en) PEPTIDES, THEIR PREPARATION AND USE OF THE BINDING OF IMMUNE LOBULINS
WO1998055508A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
MX9705710A (en) Compounds with growth hormone releasing properties.
BR1100309A (en) Peptide and pharmaceutical composition to promote the release of growth hormone levels in animals
DE69532760D1 (en) AGENTS FOR THE ADMINISTRATION OF ANTIGENS
TW200602071A (en) Methods for preventing and treating alzheimer's disease (ad)
DE69518760D1 (en) GROWTH DIFFERENTIATION FACTOR-12
GB0127983D0 (en) Treatment of micro-organism infection
DE3685651D1 (en) PEPTIDES CORRESPONDING TO THE ANTIGENIC AND IMMUNOGENIC DETERMINANTS OF IMPORTANT NEUTRALIZING PROTEINS OF THE ROTAVIRUS.
SG63621A1 (en) Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
DE69828801D1 (en) PEPTIDE DERIVED FROM THE BINDING (G) PROTEIN OF THE RESPIRATORY SYNZYTIALVIRUS
EE9800334A (en) Nucleic and amino acid sequences associated with Helicobacter pylor and vaccine compositions derived therefrom
EP1037918A4 (en) Method and composition to enhance the efficacy of a vaccine using chemokines
EP0855181A3 (en) Medicament or nutritional formulation for immune-modulation with amino acids
CO4820441A1 (en) ANTIGEN BM 95 OF THE TICK BOOPHILUS MICROPLUS, ISOLATION, SEQUENCE, RECOMBINANT DNA, TRANSFORMED MICROORGANISMS AND VACCINE PREPARATION
GB9612214D0 (en) Vaccine
WO2001096379A3 (en) Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
NO20005081D0 (en) A polypeptide containing the amino acid of an N-terminal choline binding protein A-truncate, vaccine derived therefrom and uses thereof
ATE159172T1 (en) PEPTIDES AND THEIR USE
NZ504532A (en) Use of cement proteins derived from ticks as glues for animal tissues and as vaccinations against tick borne diseases
ES2176334T3 (en) THE USE OF GABAPENTIN IN THE TREATMENT OF ANXIETY AND PANIC.
IT1217314B (en) SYNTHETIC NONAPEPTIDE WITH ADJUVANT ACTIVITY CAPABLE OF ENHANCING THE ANTI-CORPORAL RESPONSE IN VIVO
EP1557466A4 (en) Tumor antigen protein and utilization thereof